Circulating Tight Junction Proteins in Acute Ischemic Stroke Patients after Reperfusion Therapy combined with Cerebrolysin

Prof. Slawomir Michalak presented new research on blood–brain barrier integrity and endothelial protection during the hyperacute phase of stroke, highlighting the role of Cerebrolysin in stabilizing tight junction proteins and reducing the risk of hemorrhagic transformation when used alongside reperfusion therapy.